Genius J, Dastros-Pitei D, Detalle L, Domange C, Kadima H, Key-Prato M, Long J, Mathy FX, Schmidt A, Smit JW, Streffer J, Basile P. Results from a Phase 1b Study of UCB0599, an Orally Available, Brain-penetrant Inhibitor of Alphasynuclein (ASYN) Misfolding in People Living with Parkinson’s Disease (PD) (2025). Neurology Supplement, April 13, 2021
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.